NCODA Clinical Advances Summit

Event Details

Connecting scientific advances to patient-centered care

The NCODA Clinical Advances Summit (NCAS) will bring together hematology and oncology professionals to explore scientific breakthroughs and connect new evidence with practical approaches to patient care.

Beginning in 2027, NCAS will replace the NCODA International Fall Summit, building on its foundation with a larger scientific and clinical program and broader multidisciplinary and international participation.

The three-day, in-person Summit will highlight significant scientific and treatment advances from the preceding year and look ahead to developments expected to shape cancer care over the next 12–24 months. At its center is a shared purpose: equipping the medically integrated oncology team to help patients benefit from scientific progress.

Read NCAS announcement HERE

What to Expect

The planned program will pair scientific reviews with multidisciplinary discussions of care delivery and clinical implementation, including:

• Scientific and treatment advances: Emerging therapies, real-world evidence, and significant developments from the past year.
• A look ahead: Developments expected to shape cancer care over the next 12–24 months.
• Evidence into practice: Practical approaches to biomarker testing, treatment monitoring, and adherence.
• Care delivery and patient access: Health economics, policy, staffing, financial barriers, and innovations that affect the patient experience.

Meeting Leadership

NCAS Co-Chairs: Lucio Gordan, MD and Michael Reff, RPh, MBA
Working alongside an expert multidisciplinary Steering Committee to shape the meeting’s scientific direction.

Save the Date

Join us in Orlando, October 27–29, 2027. Additional details about the program, faculty, and registration will be shared as planning progresses.

2027 Save the Date  2028 Save the Date